cyc 202 has been researched along with sb 218078 in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (sb 218078) | Trials (sb 218078) | Recent Studies (post-2010) (sb 218078) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 14 | 0 | 9 |
| Protein | Taxonomy | cyc 202 (IC50) | sb 218078 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | 0.015 | |
| G1/S-specific cyclin-E2 | Homo sapiens (human) | 0.68 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.61 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.25 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.575 | |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.575 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.6333 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.6333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for cyc 202 and sb 218078
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |